PubMed:32518941
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 21-33 | MOP:0002162 | denotes | N-glycosites |
T2 | 23-33 | CHEBI:17089 | denotes | glycosites |
T3 | 23-33 | CHEBI:17089 | denotes | glycosites |
T4 | 37-55 | PG_18 | denotes | spike glycoprotein |
T5 | 37-55 | PG_1 | denotes | spike glycoprotein |
T6 | 43-55 | CHEBI:17089 | denotes | glycoprotein |
T7 | 43-55 | CHEBI:17089 | denotes | glycoprotein |
T8 | 43-55 | BV_11 | denotes | glycoprotein |
T9 | 59-69 | SP_7 | denotes | SARS-CoV-2 |
T10 | 85-92 | GO:0009986 | denotes | surface |
T11 | 93-105 | CHEBI:24396 | denotes | glycopeptide |
T12 | 93-105 | CHEBI:24396 | denotes | glycopeptide |
T13 | 147-155 | GO:0042571 | denotes | antibody |
T14 | 170-183 | NCBITaxon:11118 | denotes | Coronaviruses |
T15 | 191-196 | SP_6 | denotes | human |
T16 | 191-196 | NCBITaxon:9606 | denotes | human |
T17 | 227-231 | UBERON:0010166 | denotes | coat |
T18 | 247-260 | CHEBI:17089 | denotes | glycoproteins |
T19 | 247-260 | BV_11 | denotes | glycoproteins |
T20 | 247-260 | CHEBI:17089 | denotes | glycoproteins |
T21 | 286-291 | SP_6 | denotes | human |
T22 | 286-291 | NCBITaxon:9606 | denotes | human |
T23 | 292-302 | GO:0042571 | denotes | antibodies |
T24 | 321-330 | CHEBI:59132 | denotes | antigenic |
T25 | 321-330 | CHEBI:59132 | denotes | antigenic |
T26 | 331-336 | NCBITaxon:10239 | denotes | viral |
T27 | 345-353 | BV_9 | denotes | epitopes |
T28 | 374-378 | UBERON:0010166 | denotes | coat |
T29 | 409-415 | NCBITaxon:6960 | denotes | insect |
T30 | 463-468 | SP_6 | denotes | human |
T31 | 463-468 | NCBITaxon:9606 | denotes | human |
T32 | 480-486 | NCBITaxon:6960 | denotes | insect |
T33 | 548-552 | CHEBI:77182 | denotes | Food |
T34 | 548-552 | CHEBI:77182 | denotes | Food |
T35 | 557-561 | CHEBI:23888 | denotes | Drug |
T36 | 557-561 | CHEBI:23888 | denotes | Drug |
T37 | 617-664 | SP_7 | denotes | severe acute respiratory syndrome coronavirus 2 |
T38 | 630-641 | UBERON:0001004 | denotes | respiratory |
T39 | 630-641 | GO:0045333 | denotes | respiratory |
T40 | 666-676 | SP_7 | denotes | SARS-CoV-2 |
T41 | 692-700 | GO:0009306 | denotes | secreted |
T42 | 719-725 | NCBITaxon:6960 | denotes | insect |
T43 | 736-743 | PR:000027795 | denotes | trypsin |
T44 | 870-883 | CHEBI:24396 | denotes | glycopeptides |
T45 | 870-883 | CHEBI:24396 | denotes | glycopeptides |
T46 | 904-918 | MOP:0002162 | denotes | N-glycosylated |
T47 | 1013-1021 | CHEBI:10545 | denotes | electron |
T48 | 1013-1021 | CHEBI:10545 | denotes | electron |
T49 | 1037-1044 | SO:0000853 | denotes | homolog |
T50 | 1079-1089 | GO:0042571 | denotes | antibodies |
T51 | 1103-1111 | SP_10 | denotes | SARS-CoV |
T52 | 1122-1136 | MOP:0002162 | denotes | N-glycosylated |
T53 | 1146-1156 | SP_7 | denotes | SARS-CoV-2 |
T54 | 1178-1185 | CHEBI:37684 | denotes | mannose |
T55 | 1178-1185 | CHEBI:37684 | denotes | mannose |
T56 | 1188-1195 | MOP:0002162 | denotes | glycans |
T57 | 1188-1195 | CHEBI:59520 | denotes | glycans |
T58 | 1188-1195 | CHEBI:59520 | denotes | glycans |
T59 | 1241-1253 | CHEBI:24396 | denotes | glycopeptide |
T60 | 1241-1253 | CHEBI:24396 | denotes | glycopeptide |
T61 | 1266-1274 | CHEBI:10545 | denotes | Electron |
T62 | 1266-1274 | CHEBI:10545 | denotes | Electron |
T63 | 1288-1295 | CHEBI:17089 | denotes | glycans |
T64 | 1288-1295 | CHEBI:17089 | denotes | glycans |
T65 | 1337-1343 | SO:0000417 | denotes | domain |
T66 | 1347-1357 | SP_7 | denotes | SARS-CoV-2 |
T67 | 1459-1467 | SP_10 | denotes | SARS-CoV |
T68 | 1493-1500 | SO:0000417 | denotes | domains |
T69 | 1534-1539 | SO:0001114 | denotes | helix |
T70 | 1591-1597 | SO:0000417 | denotes | domain |
T71 | 1623-1631 | GO:0042571 | denotes | antibody |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 1178-1185 | Glycan_Motif | denotes | mannose | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G70323CJ |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-169 | Sentence | denotes | Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics. |
T2 | 170-261 | Sentence | denotes | Coronaviruses hijack human enzymes to assemble the sugar coat on their spike glycoproteins. |
T3 | 262-391 | Sentence | denotes | The mechanisms by which human antibodies may recognize the antigenic viral peptide epitopes hidden by the sugar coat are unknown. |
T4 | 392-577 | Sentence | denotes | Glycosylation by insect cells differs from the native form produced in human cells, but insect cell-derived influenza vaccines have been approved by the US Food and Drug Administration. |
T5 | 578-810 | Sentence | denotes | In this study, we analyzed recombinant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein secreted from BTI-Tn-5B1-4 insect cells, by trypsin and chymotrypsin digestion followed by mass spectrometry analysis. |
T6 | 811-925 | Sentence | denotes | We acquired tandem mass spectrometry (MS/MS) spectrums for glycopeptides of all 22 predicted N-glycosylated sites. |
T7 | 926-1114 | Sentence | denotes | We further analyzed the surface accessibility of spike proteins according to cryogenic electron microscopy and homolog-modeled structures, and available antibodies that bind to SARS-CoV-1. |
T8 | 1115-1196 | Sentence | denotes | All 22 N-glycosylated sites of SARS-CoV-2 are modified by high-mannose N-glycans. |
T9 | 1197-1265 | Sentence | denotes | MS/MS fragmentation clearly established the glycopeptide identities. |
T10 | 1266-1470 | Sentence | denotes | Electron densities of glycans cover most of the spike receptor-binding domain of SARS-CoV-2, except YQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQ, similar to a region FSPDGKPCTPPALNCYWPLNDYGFYTTTGIGYQ in SARS-CoV-1. |
T11 | 1471-1598 | Sentence | denotes | Other surface-exposed domains include those located on central helix, connecting region, heptad repeats, and N-terminal domain. |
T12 | 1599-1917 | Sentence | denotes | Because the majority of antibody paratopes bind to the peptide portion with or without sugar modification, we propose a snake-catching model for predicted paratopes: a minimal length of peptide is first clamped by a paratope, and sugar modifications close to the peptide either strengthen or do not hinder the binding. |
T1 | 0-169 | Sentence | denotes | Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics. |
T2 | 170-261 | Sentence | denotes | Coronaviruses hijack human enzymes to assemble the sugar coat on their spike glycoproteins. |
T3 | 262-391 | Sentence | denotes | The mechanisms by which human antibodies may recognize the antigenic viral peptide epitopes hidden by the sugar coat are unknown. |
T4 | 392-577 | Sentence | denotes | Glycosylation by insect cells differs from the native form produced in human cells, but insect cell-derived influenza vaccines have been approved by the US Food and Drug Administration. |
T5 | 578-810 | Sentence | denotes | In this study, we analyzed recombinant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein secreted from BTI-Tn-5B1-4 insect cells, by trypsin and chymotrypsin digestion followed by mass spectrometry analysis. |
T6 | 811-925 | Sentence | denotes | We acquired tandem mass spectrometry (MS/MS) spectrums for glycopeptides of all 22 predicted N-glycosylated sites. |
T7 | 926-1114 | Sentence | denotes | We further analyzed the surface accessibility of spike proteins according to cryogenic electron microscopy and homolog-modeled structures, and available antibodies that bind to SARS-CoV-1. |
T8 | 1115-1196 | Sentence | denotes | All 22 N-glycosylated sites of SARS-CoV-2 are modified by high-mannose N-glycans. |
T9 | 1197-1265 | Sentence | denotes | MS/MS fragmentation clearly established the glycopeptide identities. |
T10 | 1266-1470 | Sentence | denotes | Electron densities of glycans cover most of the spike receptor-binding domain of SARS-CoV-2, except YQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQ, similar to a region FSPDGKPCTPPALNCYWPLNDYGFYTTTGIGYQ in SARS-CoV-1. |
T11 | 1471-1598 | Sentence | denotes | Other surface-exposed domains include those located on central helix, connecting region, heptad repeats, and N-terminal domain. |
T12 | 1599-1917 | Sentence | denotes | Because the majority of antibody paratopes bind to the peptide portion with or without sugar modification, we propose a snake-catching model for predicted paratopes: a minimal length of peptide is first clamped by a paratope, and sugar modifications close to the peptide either strengthen or do not hinder the binding. |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1178-1185 | https://glytoucan.org/Structures/Glycans/G70323CJ | denotes | mannose |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 59-69 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T2 | 500-509 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T3 | 617-664 | Disease | denotes | severe acute respiratory syndrome coronavirus 2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 666-676 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T5 | 1103-1111 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 1146-1156 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 1347-1357 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T8 | 1459-1467 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 59-67 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T2 | 191-196 | OrganismTaxon | denotes | human | 9606 |
T3 | 286-291 | OrganismTaxon | denotes | human | 9606 |
T4 | 463-468 | OrganismTaxon | denotes | human | 9606 |
T5 | 617-650 | OrganismTaxon | denotes | severe acute respiratory syndrome | 694009 |
T6 | 666-674 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T7 | 1103-1111 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T8 | 1146-1154 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T9 | 1347-1355 | OrganismTaxon | denotes | SARS-CoV | 694009 |
T10 | 1459-1467 | OrganismTaxon | denotes | SARS-CoV | 694009 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1534-1539 | Body_part | denotes | helix | http://purl.obolibrary.org/obo/UBERON_0002488 |